Splet22. dec. 2024 · In the third quarter of 2024, SWAV incurred R&D expenses of $20.2 million, up 46.9% from the prior-year quarter’s figure. For 2024, Shockwave Medical expects revenues in the range of $483-$488... SpletShockWave Medical's (NASDAQ:SWAV) investors will be pleased with their incredible 373% return over the last three years. Simply Wall St. Dec-31-22 06:15AM. ShockWave Medical, Inc. (NASDAQ:SWAV) Q3 2024 Earnings Call Transcript.

ShockWave Medical (SWAV) Posts Solid Preliminary Q4 Revenues

SpletShockwave Medical, Inc. (SWAV) stock price, news, quote & history – Yahoo Finance ️ Sign up Shockwave Medical, Inc. (SWAV) NasdaqGS - NasdaqGS Real-time price. … Splet07. dec. 2024 · Shockwave Medical reported third-quarter 2024 earnings per share (EPS) of 92 cents, which surpassed the Zacks Consensus Estimate of 68 cents by 35.3%. It had reported an EPS of 5 cents in the... gary thorpe facebook

Shockwave Medical, Inc. (SWAV) - Yahoo Finance

Splet12. apr. 2024 · Shockwave Medical SWAV shares ended the last trading session 10.6% higher at $251.05. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. Splet19. jan. 2024 · 19 January 2024, 9:42 am · 4-min read. ShockWave Medical, Inc. SWAV announced preliminary revenues for the fourth quarter and full-year 2024 on Jan 17. The preliminary results drove down the shares of the company by 6% till the last trading session. The company is scheduled to release fourth-quarter results on Feb 16, before the opening … Splet13. okt. 2024 · 13 October 2024, 6:00 pm · 3-min read Shockwave Medical (SWAV) closed at $274.67 in the latest trading session, marking a +1.84% move from the prior day. This move lagged the S&P 500's daily gain... gary thornton spencer